Publikationen 2014
- (2014) The clinical significance of anaemia and disturbed iron homeostasis in chronic respiratory failure. Int J Clin Pract. 2014;68(1): 130-8
- (2014) Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia. Blood. 2014;123(17): 2663-72
- (2014) New insights into the interaction of Mycobacterium tuberculosis and human macrophages. Future Microbiol. 2014;9(): 327-41
- (2014) Null mutation in PGAP1 impairing Gpi-anchor maturation in patients with intellectual disability and encephalopathy. PLoS Genet. 2014;10(5): e1004320
- (2014) Targeting high-grade B cell lymphoma with CD19-specific T cells. Int J Cancer. 2014;135(5): 1153-64
- (2014) Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials. Lancet Oncol. 2014;15(3): 297-304
- (2014) Human leukocyte antigen-DO regulates surface presentation of human leukocyte antigen class II-restricted antigens on B cell malignancies. Biol Blood Marrow Transplant. 2014;20(5): 742-7
- (2014) Nilotinib combined with interleukin-2 mediates antitumor and immunological effects in a B16 melanoma model. Oncol Rep. 2014;31(5): 2015-20
- (2014) CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124(5): 750-60
- (2014) [Unclear tumour of the ear lobe]. Laryngorhinootologie. 2014;93(7): 469-70
- (2014) Over-the-scope-clipping in colonic perforation caused small-bowel fixation and pneumoperitoneum requiring surgical repair. Endoscopy. 2014;46 Suppl 1(): E314-5
- (2014) A humanized mouse identifies the bone marrow as a niche with low therapeutic IgG activity. Cell Rep. 2014;7(1): 236-48
- (2014) Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency. Blood. 2014;124(6): 851-60
- (2014) Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib. Leukemia. 2014;28(10): 1988-92
- (2014) Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Ann Hematol. 2014;93(9): 1449-56
- (2014) Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib. Haematologica. 2014;99(9): 1441-7
- (2014) Older patients with chronic myeloid leukemia (>=65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV. Ann Hematol. 2014;93(7): 1167-76
- (2014) Regression of eosinophil counts after diagnosis of chronic graft-versus-host disease as a potential marker for improved clinical outcome. Mol Clin Oncol. 2014;2(1): 81-86
- (2014) Macrophages and dendritic cells as actors in the immune reaction of classical hodgkin lymphoma. PLoS ONE. 2014;9(12): e114345
- (2014) Labeling of cancer cells with magnetic nanoparticles for magnetic resonance imaging. Magn Reson Med. 2014;71(5): 1896-905
- (2014) [In Process Citation]. Oncology Research and Treatment. 2014;37 Suppl 4(): 1
- (2014) Autocrine impact of VEGF-A on uveal melanoma cells. Invest Ophthalmol Vis Sci. 2014;55(4): 2697-704
- (2014) Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato-oncological high-risk patients: a web-based non-interventional trial in four large university hospitals in Germany. Transpl Infect Dis. 2014;16(6): 968-74
- (2014) DOTting the path to doom: how acceleration of histone methylation leads to leukemia. Cancer Cell. 2014;26(6): 781-2
- (2014) Advances in cellular therapy: 7th international symposium on the clinical use of cellular products, March 14 and 15, 2013, Erlangen, Germany. Cancer Immunol Immunother. 2014;63(2): 185-93
- (2014) Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV. Ann Hematol. 2014;93(1): 71-80
- (2014) Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation. Haematologica. 2014;99(2): 365-9
- (2014) A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cells. MAbs. 2014;6(1): 286-96
- (2014) Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV. J Clin Oncol. 2014;32(5): 415-23
- (2014) Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies Transpl Int. 2014;27(3): 253-261